Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Stem Cell Transplant for Lymphoma, Myeloma, and CLL
NCT00612716Phase 2Completed
- Sponsor
- Masonic Cancer Center
- Start
- Oct 1999
- Primary completion
- Nov 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic hematopoietic stem cells in lymphoma, multiple myeloma (MM), chronic lymphocytic leukemia (CLL), sponsored by Masonic Cancer Center. Started Oct 1999; status: completed.
02
Drugs
allogeneic hematopoietic stem cells
03
Conditions
lymphomamultiple myeloma (MM)chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00612716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00612716.